Author

Nima Almassi

Cleveland ClinicORCID 0000-0002-6307-9268Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Angela H. TingiD· 1 shared Arvind RaviiD· 1 shared Booki MiniD· 1 shared Byron LeeiD· 1 shared Emily E. FinkiD· 1 shared Gad A. GetziD· 1 shared Hong QiuiD· 1 shared Ivan JurićiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angela H. TingORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Single Cell RNA-sequencing of BCG naive and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM mediated immune-suppressive pathway

Ivan Jurić, Emily E. Fink, Hong Qiu, P. Desprez, Arvind Ravi, Mark Holton, Vladimir Makarov, Nima Almassi, Booki Min, Gad A. Getz, Timothy An-thy Chan, Tyler Joseph Alban, Angela H. Ting, Byron Lee

This study uses single-cell RNA sequencing to identify a CD6/ALCAM-mediated immune-suppressive pathway in recurrent NMIBC, suggesting CD6 as a potential therapeutic target.

npj Precision Oncology · Sep 26, 2025Peer-reviewedCancer Biology